Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5

Abstract

The human cytochrome P450 (CYP) enzymes CYP3A4 and CYP3A5 metabolize most drugs and have high similarities in their structure and substrate preference. Whereas CYP3A4 is predominantly expressed in the liver, CYP3A5 is upregulated in cancer, contributing to drug resistance. Selective inhibitors of CYP3A5 are, therefore, critical to validating it as a therapeutic target. Here we report clobetasol propionate (clobetasol) as a potent and selective CYP3A5 inhibitor identified by high-throughput screening using enzymatic and cell-based assays. Molecular dynamics simulations suggest a close proximity of clobetasol to the heme in CYP3A5 but not in CYP3A4. UV–visible spectroscopy and electron paramagnetic resonance analyses confirmed the formation of an inhibitory type I heme–clobetasol complex in CYP3A5 but not in CYP3A4, thus explaining the CYP3A5 selectivity of clobetasol. Our results provide a structural basis for selective CYP3A5 inhibition, along with mechanistic insights, and highlight clobetasol as an important chemical tool for target validation.

Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus

“…MDS was performed using Desmond modules of the Schrodinger 2019–4 as per published methods [ 24 ] using the OPLS3e force field. The system was built for the protein-ligand complex using the TIP3P solvent model; sodium ion was added to make charge-neutral, 0.15 M NaCl was added to make the system close to the natural system.…”

Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease

“…However, most small molecule inhibitors of CYP3A5 also tend to inhibit CYP3A4, creating the potential for toxic, drug-drug interactions 45 , 46 . Recenlty, clobetasol propionate (clobetasol), a potent topical corticosteroid used to treat psoriasis, was identified as a potent and selective CYP3A5 inhibitor 47 , 48 . Here we demonstrate that CYP3A5 expression can alternatively be modulated using ASOs that interact with target RNA via Watson–Crick base pairing 49 , 50 .…”

A molecular dynamics simulation study of the ACE2 receptor with screened natural inhibitors to identify novel drug candidate against COVID-19

“…The molecular dynamic simulation study was performed to examine the conformational changes in the protein that occurred due to the ligand-binding site and to evaluate the effect of these changes over the protein-ligand complex ( Yue et al, 2017 ; Okimoto et al, 2009 ). To evaluate the stability and interaction of the ACE2 receptor with ligand simulation study was performed using Desmond v12 Schrödinger software package at 50 ns time period ( Wright et al, 2020 ). The complex was placed in protein preparation wizard for optimization, analysis, and refinement of docking complex, system builder menu set up membrane model POPC (Palmitoyl Oleoyl Phasphatidyl chlorine).…”